{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T10:22:27Z","timestamp":1648549347316},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T00:00:00Z","timestamp":1196899200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1007\/s12185-007-0012-0","type":"journal-article","created":{"date-parts":[[2008,1,15]],"date-time":"2008-01-15T05:13:39Z","timestamp":1200374019000},"page":"56-59","source":"Crossref","is-referenced-by-count":0,"title":["Dramatic remission of anemia after thymectomy in a patient of idiopathic myelofibrosis with thymoma"],"prefix":"10.1007","volume":"87","author":[{"given":"Ying-Yih","family":"Shih","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-Tsai","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Fen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzeon-Jye","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,12,6]]},"reference":[{"key":"12_CR1","first-page":"1295","volume-title":"Williams hematology","author":"MA Lichtman","year":"2006","unstructured":"Lichtman MA. Idiopathic myelofibrosis (myelofibrosis with myeloid metaplasia). In: Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Kaushansky K, Prchal JT, editors. Williams hematology. 7th ed. New York: McGraw-Hill; 2006. p. 1295\u2013313.","edition":"7th ed"},{"key":"12_CR2","first-page":"35","volume-title":"World Health Organization Classification of Tumours","author":"J Thiele","year":"2001","unstructured":"Thiele J, Pierre R, Imbert M, Vardiman JW, Brunning RD, Flandrin G. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization Classification of Tumours. Lyon: IARC; 2001. p. 35\u20138."},{"key":"12_CR3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/hon.771","volume":"24","author":"JT Reilly","year":"2006","unstructured":"Reilly JT. Idiopathic myelofibrosis: pathogenesis to treatment. Hematol Oncol. 2006;24:56\u201363.","journal-title":"Hematol Oncol"},{"key":"12_CR4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archinte.1984.00350160117020","volume":"144","author":"EC Rosenow 3rd","year":"1984","unstructured":"Rosenow EC 3rd, Hurley BT. Disorders of the thymus. A review. Arch Intern Med. 1984;144:763\u201370.","journal-title":"Arch Intern Med"},{"key":"12_CR5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000206162","volume":"74","author":"I Rubinstein","year":"1985","unstructured":"Rubinstein I, Langevitz P, Hirsch R, Berkowicz M, Lieberman Y, Shibi G. Autoimmune hemolytic anemia as the presenting manifestation of malignant thymoma. Acta Haematol. 1985;74:40\u20132.","journal-title":"Acta Haematol"},{"key":"12_CR6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archinte.1974.00320200184029","volume":"134","author":"JV Souadjian","year":"1974","unstructured":"Souadjian JV, Enriquez P, Silverstein MN, Pepin JM. The spectrum of diseases associated with thymoma. Coincidence or syndrome? Arch Intern Med. 1974;134:374\u20139.","journal-title":"Arch Intern Med"},{"key":"12_CR7","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1182\/blood-2005-04-1520","volume":"106","author":"G Barosi","year":"2005","unstructured":"Barosi G, Bordessoule D, Briere J, Cervantes F, Demory JL, Dupriez B, et al. Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET). Blood. 2005;106:2849\u201353.","journal-title":"Blood"},{"key":"12_CR8","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM200004273421706","volume":"342","author":"A Tefferi","year":"2000","unstructured":"Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 2000;342:1255\u201365.","journal-title":"N Engl J Med"},{"key":"12_CR9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ajh.2830230409","volume":"23","author":"SM Lippman","year":"1986","unstructured":"Lippman SM, Durie BG, Garewal HS, Giordano G, Greenberg BR. Efficacy of danazol in pure red cell aplasia. Am J Hematol. 1986;23:373\u20139.","journal-title":"Am J Hematol"},{"key":"12_CR10","first-page":"707","volume":"18","author":"AM Tan","year":"1989","unstructured":"Tan AM, Lou J, Cheng HK. Danazol for treatment of refractory autoimmune hemolytic anaemia. Ann Acad Med Singapore. 1989;18:707\u20139.","journal-title":"Ann Acad Med Singapore"},{"key":"12_CR11","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1442-200X.1996.tb03724.x","volume":"38","author":"H Shichino","year":"1996","unstructured":"Shichino H, Mugishima H, Takamura M, Shimada T, Suzuki T, Chin M, et al. Treatment of aplastic anemia with antithymocyte globulin, cyclosporin A, methylprednisolone, danazol and recombinant human granulocyte-colony stimulating factor. Acta Paediatr Jpn. 1996;38:644\u20137.","journal-title":"Acta Paediatr Jpn"},{"key":"12_CR12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2169\/internalmedicine1962.29.417","volume":"29","author":"M Murakawa","year":"1990","unstructured":"Murakawa M, Shibuya T, Harada M, Okamura T, Asano Y, Okamura H, et al. Danazol treatment for paroxysmal nocturnal hemoglobinuria. Jpn J Med. 1990;29:417\u201322.","journal-title":"Jpn J Med"},{"key":"12_CR13","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/1096-8652(200008)64:4<306::AID-AJH12>3.0.CO;2-V","volume":"64","author":"I Sadek","year":"2000","unstructured":"Sadek I, Zayed E, Hayne O, Fernandez L. Prolonged complete remission of myelodysplastic syndrome treated with danazol, retinoic acid and low-dose prednisone. Am J Hematol. 2000;64:306\u201310.","journal-title":"Am J Hematol"},{"key":"12_CR14","first-page":"595","volume":"85","author":"F Cervantes","year":"2000","unstructured":"Cervantes F, Hernandez-Boluda JC, Alvarez A, Nadal E, Montserrat E. Danazol treatment of idiopathic myelofibrosis with severe anemia. Haematologica. 2000;85:595\u20139.","journal-title":"Haematologica"},{"key":"12_CR15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2141.2005.05524.x","volume":"129","author":"F Cervantes","year":"2005","unstructured":"Cervantes F, Alvarez-Larran A, Domingo A, Arellano-Rodrigo E, Montserrat E. Efficacy and tolerability of danazol as a treatment for the anaemia of myelofibrosis with myeloid metaplasia: long-term results in 30 patients. Br J Haematol. 2005;129:771\u20135.","journal-title":"Br J Haematol"},{"key":"12_CR16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ajh.20183","volume":"77","author":"I Velazquez","year":"2004","unstructured":"Velazquez I, Alter BP. Androgens and liver tumors: Fanconi\u2019s anemia and non-Fanconi\u2019s conditions. Am J Hematol. 2004;77:257\u201367.","journal-title":"Am J Hematol"},{"key":"12_CR17","first-page":"5142","volume":"9","author":"CM Cottreau","year":"2003","unstructured":"Cottreau CM, Ness RB, Modugno F, Allen GO, Goodman MT. Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer. Clin Cancer Res. 2003;9:5142\u20134.","journal-title":"Clin Cancer Res"},{"key":"12_CR18","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0025-7125(16)31841-7","volume":"60","author":"SB Krantz","year":"1976","unstructured":"Krantz SB. Diagnosis and treatment of pure red cell aplasia. Med Clin North Am. 1976;60:945\u201358.","journal-title":"Med Clin North Am"},{"key":"12_CR19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0300-2977(96)00084-8","volume":"50","author":"RJ Rennenberg","year":"1997","unstructured":"Rennenberg RJ, Pauwels P, Vlasveld LT. A case of thymoma-associated autoimmune haemolytic anaemia. Neth J Med. 1997;50:110\u20134.","journal-title":"Neth J Med"},{"key":"12_CR20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ajh.10258","volume":"72","author":"V Pullarkat","year":"2003","unstructured":"Pullarkat V, Bass RD, Gong JZ, Feinstein DI, Brynes RK. Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome. Am J Hematol. 2003;72:8\u201312.","journal-title":"Am J Hematol"},{"key":"12_CR21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/(SICI)1096-8652(199810)59:2<133::AID-AJH6>3.0.CO;2-Z","volume":"59","author":"P Rameshwar","year":"1998","unstructured":"Rameshwar P, Chang VT, Thacker UF, Gascon P. Systemic transforming growth factor-beta in patients with bone marrow fibrosis\u2013\u2013pathophysiological implications. Am J Hematol. 1998;59:133\u201342.","journal-title":"Am J Hematol"},{"key":"12_CR22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1034\/j.1600-0609.2001.00302.x","volume":"66","author":"Y Abe","year":"2001","unstructured":"Abe Y, Ohshima K, Shiratsuchi M, Honda K, Nishimura J, Nawata H, et al. Cytotoxic T-cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF-beta. Eur J Haematol. 2001;66:210\u20132.","journal-title":"Eur J Haematol"},{"key":"12_CR23","first-page":"54","volume":"81","author":"G Altomare","year":"1996","unstructured":"Altomare G, Capella GL, Frigerio E. Sweet\u2019s syndrome in a patient with idiopathic myelofibrosis and thymoma\u2013myasthenia gravis-immunodeficiency complex: efficacy of treatment with etretinate. Haematologica. 1996;81:54\u20138.","journal-title":"Haematologica"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-007-0012-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-007-0012-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-007-0012-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T04:57:02Z","timestamp":1559451422000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-007-0012-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,6]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["12"],"URL":"https:\/\/doi.org\/10.1007\/s12185-007-0012-0","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,6]]}}}